Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-10-17

FDA Approved: SINCALIDE — Supplemental Application (MAIA Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Sincalide from MAIA Pharmaceuticals, likely affecting the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sincalide (sincalide)

Snippet

SUPPL AP for SINCALIDE (SINCALIDE)